D28581615A_Response_Package_HTH-2014-00299.PDF
D28581515A_Response_Letter_HTH-2014-00299.PDF
FOI Request - HTH-2014-00299 The submission and review of Varenicline Tartrate by Pharmaceutical Services Division, within the timeframe of May 4, 2007 to December 10, 2010; The resubmission and approval decision, within the timeframe of December 10, 2010 to September 30, 2011; the clinical evidence review, with the proprietary material redacted. All correspondence within the Pharmaceutical Services Division and the Drug Benefit Council regarding Varenicline Tartrate between May 4, 2007 and September 30, 2011. FOI Request FOI Request 2015-06-17 Health 6 2015 D28581515A_Response_Letter_HTH-2014-00299.PDF D28581615A_Response_Package_HTH-2014-00299.PDF Political Party $0.00